ArticleVeterinary sciences2025
Efficacy of Aqueous Moringa Oleifera Leaf Extract as a Natural Alternative to Antibiotics in Broiler Chickens: Impacts on Growth, Digestibility, and Blood Lipid Profile.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Phytogenic as a natural resource for gut health management: a sustainable strategy for modern poultry production.Veterinary and animal science · 2026Review
- Antimicrobial resistance in poultry meat in the mediterranean region: prevalence, public health implications, and control strategies: A review.Poultry science · 2026Review
- The Effects of Sage (Veterinary sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Excessive use of antibiotic growth promoters (AGPs) in broiler rearing has led to severe issues due to antimicrobial resistance and drug residues in meat. This study was conducted to evaluate aqueous Moringa oleifera leaf extract (MOLE) as a natural alternative to antibiotics in broiler chickens. 150 broiler chicks were randomly distributed into five groups: one control, three MOLE-treated groups (60, 90, and 120 mL/L), and one Enrofloxacin-treated group (an antibiotic). The birds were monitored for a 35-day trial period, split further into a starter phase (0-21 days) and a finisher phase (22-35 days). The results were that at the starter phase of their lives, birds treated with MOLE120 experienced better body weight gain and optimal feed conversion ratio (FCR), which showed improved early growth performance. In the finisher phase, the MOLE90 group demonstrated the best FCR and a favorable weight gain, showing better efficiency at later stages. Crude protein digestibility was highest in the MOLE90 group (69.97%), and apparent metabolizable energy also increased in all MOLE-treated groups, especially MOLE120 (2938.9 kcal/kg). Regarding the blood lipid profile, the MOLE90 group had the lowest low-density lipoprotein (LDL) (82.3 mg/dL) and cholesterol (181.7 mg/dL), while MOLE120 achieved the highest high-density lipoprotein (HDL) level (92.6 mg/dL) with significant (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.